ZONARE Expands Commercial Shipments of New ZS3 Ultrasound System

Share Article

Company to Showcase Growing Family of Premium Ultrasound Systems at Upcoming Vascular Annual Meeting

We were very impressed with the superbly enhanced image quality, coupled with an excellent cost of ownership scenario

Visit ZONARE at VAM Booth #112.

ZONARE Medical Systems, the pioneer and developer of next generation ultrasound technology, announced it recently expanded commercial shipments of its new ZS3 system to major markets worldwide. The system has been purchased by numerous healthcare providers across the globe including the United States, Europe, Asia, Latin America, and Australia.

“We were very impressed with the superbly enhanced image quality, coupled with an excellent cost of ownership scenario,” said Aldo Ruffolo, DO, MBA, president and CEO of Lakeland Healthcare Group in Illinois. “Along with venous disease, we have expanded our practical application of this technology to include wellness screening procedures of the neck, abdomen and pelvis. The wide variety of applications addressed by the ZS3, along with an extensive array of available transducers, has enabled us to do this.”

The ZS3 uses ZONARE’s Living Technology which delivers ultrasound imaging excellence based on a dynamic and open architecture that allows continual platform evolvement. ZONE Sonography™ Technology is an innovative approach to echo data acquisition and image formation. Using a small number of large "zones," ZONE Sonography Technology acquires ultrasound data up to ten times faster and extracts more information on each transmit receive cycle than conventional ultrasound systems.    Since the speed of sound traveling through tissue is a physical constant, ZONE Sonography has a significantly faster acoustic acquisition time enabling superior image quality.

Every ZS3 system includes a five-year Image Protection warranty at no additional cost. Image Protection provides imaging enhancement software updates during the warranty period.

“We believe our unique Image Protection warranty provides significant value while enabling excellence in performance,” said Timothy A. Marcotte, president and CEO of ZONARE. “We are pleased to be providing this technology to such leading healthcare providers as Lakeland Healthcare Group and look forward to being a part of the team in the years to come.”

The ZS3 joins the growing family of ZONARE ultrasound systems. Other systems include the z.one ultra, a popular vascular imaging solution, and z.one ultra sp, a dedicated point-of-care system. The majority of all transducers are compatible across the entire product line. ZONARE will be showcasing the ZS3 and z.one ultra systems with live scanning in booth #112 at the upcoming Vascular Annual Meeting (VAM) being held May 30 - June 1, 2013 in San Francisco.

About ZONARE Medical Systems, Inc.

ZONARE Medical Systems, Inc., based in the United States’ Silicon Valley, is solely dedicated to ultrasound excellence through its innovative, software-based, next generation technology which provides the platform for the company’s Living Technology designed to meet its customers evolving imaging needs. The patented design and architecture of the ZS3 and z.one ultra ultrasound platforms deliver high-end image quality and clinical versatility at unparalleled value. All ZONARE ultrasound systems are made in the USA. ZONARE’s exclusive, next generation ultrasound focus resulted in Frost & Sullivan awarding the 2011 North American Technology Innovation Award in Diagnostic Ultrasound Imaging Technology to ZONARE. For more information, visit: http://www.zonare.com.

ZONARE, ZS3, z.one ultra, and ZONE Sonography are trademarks of ZONARE Medical Systems, Inc.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Laurie Hallwyler

Email >
Visit website